Logo image of CHRO

CHANNEL THERAPEUTICS CORP (CHRO) Stock Analyst Ratings

USA - NYSE Arca - NYSEARCA:CHRO - US1711261057 - Common Stock

1.35 USD
+0.09 (+7.14%)
Last: 7/1/2025, 9:36:41 PM
1.3699 USD
+0.02 (+1.47%)
After Hours: 7/1/2025, 9:36:41 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CHRO. The Buy consensus is the weighted average rating of the current analysts ratings.

CHRO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CHRO.
In the previous month the buy percentage consensus was at a similar level.
CHRO was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

CHRO Historical Analyst RatingsCHRO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Related screens

CHRO Current Analyst RatingCHRO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-06-18 Alliance Global Partners Initiate Buy

CHANNEL THERAPEUTICS CORP / CHRO FAQ

How do analysts rate CHANNEL THERAPEUTICS CORP (CHRO)?

The consensus rating for CHANNEL THERAPEUTICS CORP (CHRO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.